Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-05-11

Clinical Trial Update: A Study In Patients With Neuropathic Pain From Diabetic Peripheral Neuropathy (DPN) [Phase 2]

View source ↗

Summary

Phase 2 study evaluating gabapentin enacarbil for neuropathic pain in diabetic peripheral neuropathy; results posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • gabapentin enacarbil (gabapentin enacarbil)

Snippet

Sponsor: XenoPort, Inc. | Conditions: Neuropathy, Diabetic | Phase 2 | Status: COMPLETED | Results posted: 2011-05-11